SFX by Ex Libris Inc.

Title:	Targeting SLC1a5-mediated glutamine dependence in non-small cell lung cancer
Source:	International Journal of Cancer [0020-7136] Hassanein, Mohamed yr:2015

Basic

Full text

Full text available via Wiley Online Library All Journals

Year:

Volume:

Issue:

Start Page:

Full text available via Wiley Online Library Full Collection 2019

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Hassanein, M. "SLC1A5 mediates glutamine transport required for lung cancer cell growth and survival." Clinical cancer research 19.3 (2012): 560-570.
description	2.	Todorova, Valentina K. "Tamoxifen and raloxifene suppress the proliferation of estrogen receptor-negative cells through inhibition of glutamine uptake." Cancer Chemotherapy and Pharmacology 67.2 (2010): 285-291.
description	3.	Kim, S. "Expression of glutamine metabolism-related proteins according to molecular subtype of breast cancer." Endocrine-related cancer 20.3 (2013): 339-48.
description	4.	Kanai, Y. "The SLC1 high-affinity glutamate and neutral amino acid transporter family." Molecular aspects of medicine 34.2-3 (2013): 108-120.
description	5.	Penfield, Joshua D. "Menetrier's Disease Is Associated With an Increased Risk of Gastric Cancer: A Case-Control Study." Gastroenterology 2013.
description	6.	van Horssen, R. "Cancer cell metabolism regulates extracellular matrix degradation by invadopodia." European journal of cell biology 92.3 (2013): 113-21.
description	7.	Vestergaard, P. "Stroke in relation to use of raloxifene and other drugs against osteoporosis." Osteoporosis international 22.4 (2010): 1037-1045.
description	8.	Bigl, V. "Cellular distribution of 6-phosphofructo-1-kinase isoenzymes in rat brain." Journal of neurochemistry 67.6 (1996): 2573-2580.
description	9.	Holm, C. "Phosphorylation of the oestrogen receptor alpha at serine 305 and prediction of tamoxifen resistance in breast cancer." The Journal of pathology 217.3 (2009): 372-9.
description	10.	Nigam, M. "Centchroman induces G0/G1 arrest and Caspase-dependent Apoptosis involving Mitochondrial Membrane Depolarization in MCF-7 and MDA MB-231 Human Breast Cancer Cells." Life Sciences 82.11/12 (2008): 577-90.
description	11.	Rasko, J. "Hartnup disorder: polymorphisms identified in the neutral amino acid transporter SLC1A5." Journal of inherited metabolic disease 25.6: 437-448.
description	12.	Bröer, S. "Amino acid transport across mammalian intestinal and renal epithelia." Physiological reviews 88.1 (2007): 249-86.
description	13.	Kim, S. "The expression of glutamine-metabolism-related proteins in breast phyllodes tumors." Tumor biology 34.5 (2013): 2683-2689.
description	14.	Kanai, Y. "The glutamate/neutral amino acid transporter family SLC1: molecular, physiological and pharmacological aspects." Pflügers Archiv 447.5 (2004): 469-479.
description	15.	Avissar NE, Sax HC, Toia L;, Nelly E. "In Human Entrocytes, GLN Transport and ASCT2 Surface Expression Induced by Short-Term EGF are MAPK, PI3K, and Rho-Dependent." Digestive Diseases and Sciences 53.8 (2007): 2113-2125.
description	16.	Neckers, L. "The GLU that Holds Cancer Together: Targeting GLUtamine Transporters in Breast Cancer." Cancer cell 27.3 (2015): 317-9.
description	17.	Morvan, D. "Normal human melanocytes exposed to chronic insulin and glucose supplementation undergo oncogenic changes and methyl group metabolism cellular redistribution." American journal of physiology: endocrinology and metabolism 302.11 (2012).
description	18.	Rask-Andersen, M. "Solute carriers as drug targets: Current use, clinical trials and prospective." Molecular aspects of medicine 34.2-3 (2013): 702-710.
description	19.	Oyama, T. "Correlation of L-type amino acid transporter 1 and CD98 expression with triple negative breast cancer prognosis." Cancer science 103.2 (2012): 382-389.
description	20.	Seow, Heng F F. "Hartnup disorder is caused by mutations in the gene encoding the neutral amino acid transporter SLC6A19." Nature Genetics 36.9 (2004): 1003-1007.